256 related articles for article (PubMed ID: 24184124)
1. Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells.
Piccolella M; Crippa V; Messi E; Tetel MJ; Poletti A
Pharmacol Res; 2014 Jan; 79():13-20. PubMed ID: 24184124
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol.
Dondi D; Piccolella M; Biserni A; Della Torre S; Ramachandran B; Locatelli A; Rusmini P; Sau D; Caruso D; Maggi A; Ciana P; Poletti A
Endocr Relat Cancer; 2010 Sep; 17(3):731-42. PubMed ID: 20562232
[TBL] [Abstract][Full Text] [Related]
3. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
Chen J; Wang WQ; Lin SX
J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
[TBL] [Abstract][Full Text] [Related]
4. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.
Guerini V; Sau D; Scaccianoce E; Rusmini P; Ciana P; Maggi A; Martini PG; Katzenellenbogen BS; Martini L; Motta M; Poletti A
Cancer Res; 2005 Jun; 65(12):5445-53. PubMed ID: 15958594
[TBL] [Abstract][Full Text] [Related]
5. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits tumor necrosis factor alpha and lipopolysaccharide induced inflammatory response in human endothelial cells and in mice aorta.
Norata GD; Cattaneo P; Poletti A; Catapano AL
Atherosclerosis; 2010 Sep; 212(1):100-6. PubMed ID: 20557886
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
He D; Falany CN
Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
[TBL] [Abstract][Full Text] [Related]
7. Genistein versus ICI 182, 780: an ally or enemy in metastatic progression of prostate cancer.
Nakamura H; Wang Y; Xue H; Romanish MT; Mager DL; Helgason CD; Wang Y
Prostate; 2013 Dec; 73(16):1747-60. PubMed ID: 24038102
[TBL] [Abstract][Full Text] [Related]
8. 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.
Oliveira AG; Coelho PH; Guedes FD; Mahecha GA; Hess RA; Oliveira CA
Steroids; 2007 Dec; 72(14):914-22. PubMed ID: 17854852
[TBL] [Abstract][Full Text] [Related]
9. In vitro chronic administration of ERbeta selective ligands and prostate cancer cell growth: hypotheses on the selective role of 3beta-adiol in AR-positive RV1 cells.
Colciago A; Ruscica M; Mornati O; Piccolella M; Montagnani-Marelli M; Eberini I; Festuccia C; Magni P; Motta M; Negri-Cesi P
Biomed Res Int; 2014; 2014():801473. PubMed ID: 24877132
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor β and 17β-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer.
Muthusamy S; Andersson S; Kim HJ; Butler R; Waage L; Bergerheim U; Gustafsson JÅ
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20090-4. PubMed ID: 22114194
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer.
Dey P; Ström A; Gustafsson JÅ
Oncogene; 2014 Aug; 33(33):4213-25. PubMed ID: 24077289
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene.
Cao F; Jin TY; Zhou YF
Biomed Environ Sci; 2006 Feb; 19(1):35-41. PubMed ID: 16673816
[TBL] [Abstract][Full Text] [Related]
14. CYP7B1-mediated metabolism of dehydroepiandrosterone and 5alpha-androstane-3beta,17beta-diol--potential role(s) for estrogen signaling.
Pettersson H; Holmberg L; Axelson M; Norlin M
FEBS J; 2008 Apr; 275(8):1778-89. PubMed ID: 18331353
[TBL] [Abstract][Full Text] [Related]
15. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
Rajah TT; Du N; Drews N; Cohn R
Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
[TBL] [Abstract][Full Text] [Related]
16. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
17. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
[TBL] [Abstract][Full Text] [Related]
18. The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus.
Lund TD; Hinds LR; Handa RJ
J Neurosci; 2006 Feb; 26(5):1448-56. PubMed ID: 16452668
[TBL] [Abstract][Full Text] [Related]
19. Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.
Bianco NR; Perry G; Smith MA; Templeton DJ; Montano MM
Mol Endocrinol; 2003 Jul; 17(7):1344-55. PubMed ID: 12714703
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines.
Lattrich C; Stegerer A; Häring J; Schüler S; Ortmann O; Treeck O
Steroids; 2013 Feb; 78(2):195-202. PubMed ID: 23153457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
